佳士科技(300193.SZ):4145萬元競得惠州1宗工業地 擬用於新建億沃科技產業園
格隆匯1月12日丨佳士科技(300193.SZ)公佈,公司全資子公司億沃科技近日參與惠州市惠陽區國有建設用地使用權網上掛牌出讓交易活動,以4145萬元競得掛牌編號為GP2021-34宗地使用權,並與掛牌人惠州市公共資源交易中心惠陽分中心、出讓人惠州市惠陽區自然資源局簽訂了《成交確認書》〔惠陽資易土出(確)[2021]34號〕。
宗地位於三和街道象嶺村地段,土地面積為42420平方米,土地用途為工業用地,使用年限為50年。該地塊擬新建億沃科技產業園,以加快公司數字化焊機及自動化設備業務的發展,進一步提升公司的市場競爭力和持續盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.